Kaynakça
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-63.
Deng M, Ma X, Liang X, Zhu C, Wang M. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Oncotarget. 2017;8:37200-7.
Nogueiro J, Santos-Sousa H, Pereira A, et al. The impact of the prognostic nutritional index (PNI) in gastric cancer. Langenbecks Arch Surg. 2022;407:2703-14.
Gulmez A, Coskun H, Koseci T, Ata S, Bozkurt B, Cil T. Effect of microsatellite status and pan-immune-inflammation score on pathological response in patients with clinical stage III stomach cancer treated with perioperative chemotherapy. Medicina (Kaunas). 2023;59:1625.
Yazici H, Yegen SC. Is Systemic inflammatory response index (SIRI) a reliable tool for prognosis of gastric cancer patients without neoadjuvant therapy? Cureus. 2023 Mar 23;15(3):e36597.
Hirahara N, Matsubara T, Fujii Y, et al. Comparison of the prognostic value of immunoinflammation-based biomarkers in patients with gastric cancer. Oncotarget. 2020;11:2625-35.
Szczepanik AM, Paszko A, Szura M, Scully-Horner T, Kulig J. Alternative staging of regional lymph nodes in gastric cancer. Prz Gastroenterol. 2016;11:145-9.
Posteraro B, Persiani R, Dall’Armi V, et al. Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery. Eur J Surg Oncol. 2014;40:345-51.
Jiang Q, Zeng X, Zhang C, et al. Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy. World J Surg Oncol. 2022;20:261.
Zhou P, Sun X, Zeng L, et al. Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy. BMC Gastroenterol. 2024;24:371.
Agalar C, Aysal A, Unek T, et al. The role of log odds of positive lymph nodes in predicting the survival after resection for ampullary adenocarcinoma. Pathol Oncol Res. 2020;26:467-73.
Gu P, Deng J, Sun Z, et al. Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China. Surg Today. 2021;51:101-10.
Sun Z, Xu Y, Li de M, et al. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer. 2010;116:2571-80.
Qiu MZ, Qiu HJ, Wang ZQ, et al. The tumor-log odds of positive lymph nodes-metastasis staging system, a promising new staging system for gastric cancer after D2 resection in China. PLoS One. 2012;7:e31736.
Aurello P, Petrucciani N, Nigri GR, et al. Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma? J Gastrointest Surg. 2014;18:1254-60.
He X, Wu W, Lin Z, Ding Y, Si J, Sun LM. Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis. Gastric Cancer. 2018;21:391-400.
Ren JY, Xu M, Niu XD, et al. Systemic inflammatory response index is a predictor of prognosis in gastric cancer patients: retrospective cohort and meta-analysis. World J Gastrointest Surg. 2024;16:382-95.
Liu Z, Ge H, Miao Z, Shao S, Shi H, Dong C. Dynamic changes in the systemic inflammation response ındex predict the outcome of resectable gastric cancer patients. Front Oncol. 2021;11:577043.
Chen J, Hong D, Zhai Y, Shen P. Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer. World J Surg Oncol. 2015;13:122.
Wu J, Wu XD, Gao Y, Gao Y. Correlation between preoperative systemic immune-inflammatory indexes and the prognosis of gastric cancer patients. Eur Rev Med Pharmacol Sci. 2023;27:5706-20.
Wang K, Diao F, Ye Z, et al. Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Chin J Cancer. 2017;36:75.
Migita K, Takayama T, Saeki K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. 2013;20:2647-54.
Xu Z, Chen X, Yuan J, Wang C, An J, Ma X. Correlations of preoperative systematic immuno-inflammatory index and prognostic nutrition index with a prognosis of patients after radical gastric cancer surgery. Surgery. 2022;172:150-9.
Attaallah W, Uprak K, Gunal O, Yegen C. Prognostic impact of the metastatic lymph node ratio on survival in gastric cancer. Indian J Surg Oncol. 2016;7:67-72.
Ergenç M, Uprak TK, Akın Mİ, Hekimoğlu EE, Çelikel ÇA, Yeğen C. Prognostic significance of metastatic lymph node ratio in gastric cancer: a Western-center analysis. BMC Surg. 2023;23:220.
Díaz Del Arco C, Estrada Muñoz L, Sánchez Pernaute A, et al. Prognostic role of the log odds of positive lymph nodes in Western patients with resected gastric cancer: a comparison with the 8th edition of the TNM staging system. Am J Clin Pathol. 2024;161:186-96.
